Chemogenomic Profiling in Hematological Malignancies (HEM-Profiling 2021)

NCT07445984 · clinicaltrials.gov ↗

NA

Phase

RECRUITING

Status

250

Enrollment

OTHER

Sponsor class

Conditions

Chronic Leukemia
Acute Leukemia
Myeloproliferative Disorders
Lymphoproliferative Disorders
Myelodysplastic Disorders

Interventions

OTHER: Genetic, molecular and/or omics analyses

Sponsor

Azienda Ospedaliero-Universitaria di Parma